MILAN--(BUSINESS WIRE)--
Domp, the leading company in research & development of novel treatment solutions for rare diseases, announces its investigational drug based on the recombinant human nerve growth factor (rhNGF) discovered by Nobel Laureate Professor Rita Levi Montalcini has been granted orphan drug designation by the US FDA for the treatment of retinitis pigmentosa (RP). This gives new hope for the treatment of this disease for which at present there is no cure.
The orphan drug designation by the FDA comes just a few months after orphan drug designation was granted by the European Medicine Agency (EMA) and marks another milestone for this investigational drug, which is already in late-stage clinical development for the treatment of neurotrophic keratitis, a severe corneal disease.
We are particularly proud of this achievement: the orphan drug designation granted by the FDA is an important recognition for our company which is increasingly committed to producing innovation globally as testified by our direct presence in the US where we recently opened a subsidiary said Eugenio Aringhieri, CEO of the Domp Group We are strictly determined in discovering and developing prime high-tech drugs that can cure rare diseases, like retinitis pigmentosa, for which at present there are no treatment options. Our efforts are driven by our commitment to respond to the unmet needs of patients around the world based on our ability to deliver safe and effective solutions in sensitive medical areas.
Domp follows the development of rhNGF all the way, from production to clinical development. Building on initial results from the administration of the murine protein to a limited number of people with neurothropic keratitis, the company launched a dedicated project at its R&D sites to ensure the production of a drug based on recombinant human NGF (rhNGF). From that first indication, the company moved to synthesize the recombinant human protein and then assess the potential of the drug, which is entirely produced at Domp sites, also for the treatment of retinitis pigmentosa.
In the coming month a clinical trial will start to assess the efficacy and safety of rhNFG as treatment for retinitis pigmentosa. The drug is produced using recombinant DNA techniques, specifically by transferring human genetic material into a bacterium which thus becomes capable of producing NGF explains Marcello Allegretti, Chief Scientific Officer, Domp. We are currently investigating rhNFG in the phase I/II clinical trial REPARO as treatment for neurotrophic keratitis, a rare eye disease which in its most severe forms affects nearly 1 in 10,000 people worldwide. Like Retinitis Pigmentosa, currently there is no specific treatment available for neurotrophic keratitis, which is a progressive degenerative disease of the cornea that may result in blindness.
About RhNGF RhNGF, the recombinant human nerve growth factor developed by Domp, is the same type of protein as the one naturally produced by the human body that fosters development and survival of nerve cells including retinal cells. NGF has proven to be effective in inhibiting retinal degeneration in several animal models in retinitis pigmentosa. The recombinant human NGF may improve survival of retinal cells, slow down disease progression and help preserve patients vision.
About Retinitis Pigmentosa The term retinitis pigmentosa denotes a group of hereditary eye diseases with progressive loss of vision. In patients suffering from this condition the light receptors, i.e. the retinal cells known as the rods and cones that convert light images to nerve signals and sends them to the brain, get damaged and progressively degenerate. Currently retinitis pigmentosa affects about 3 in 10,000 people globally, well below the threshold set for orphan drugs. As the treatment developed by Domp is being granted orphan drug designation by the FDA, in the US there is no satisfactory targeted treatment for retinitis pigmentosa. People with this disorder receive just genetic counselling about the risk of transmitting the disease to their offspring and general support therapy.
About Domp Domp is a leading biopharmaceutical company in Italy focused on developing innovative treatment solutions for rare, often orphan, diseases. Domp pursues this goal also by proactively promoting and leveraging networking of prime players along the entire pharmaceutical supply chain from R&D through manufacturing to commercialisation. Domp is based in Italy with HQ in Milan. Its industrial site in LAquila (Abruzzi, Italy) employs 230 people, of whom 70 in R&D, and features production facilities that meet the highest industry standards in terms of both quality and technology, developing drugs that are sold worldwide In 2012, Domp Group has ploughed back over 10% of sales into R&D, focusing its commitment on therapeutic areas with unmet medical needs, such as diabetes, ophthalmology and oncology. For more information: http://www.dompe.com
Forward looking statements
Read more here:
- Amarantus Announces Positive Orphan Data for MANF in Retinitis Pigmentosa - August 14th, 2013 [August 14th, 2013]
- Amarantus BioScience - “Ophthalmology: MANF’s Orphan Strategy Coming into Focus in Retinitis Pigmentosa” - August 14th, 2013 [August 14th, 2013]
- RiverDogs Donate $20,000 to MUSC Storm Eye Institute - August 14th, 2013 [August 14th, 2013]
- Casino mogul Steve Wynn donates $25 million to find cure for eye disease he has - August 14th, 2013 [August 14th, 2013]
- Explaining Retinitis Pigmentosa, RP - Video - August 14th, 2013 [August 14th, 2013]
- FIRATLI CLINIC ISTANBUL Retinitis Pigmentosa HeilungTunnelBlick) - Video - August 18th, 2013 [August 18th, 2013]
- Treatment for retinitis pigmentosa - Video - August 18th, 2013 [August 18th, 2013]
- FIRATLI CLINIC ISTANBUL Retinitis Pigmentosa Treatment DUTCH) - Video - August 20th, 2013 [August 20th, 2013]
- FIRATLI CLINIC AvtarEngland) A MUST WATCH FOR Retinitis Pigmentosa Treatment (+Visionfieldtest) - Video - August 20th, 2013 [August 20th, 2013]
- Argus® II Retinal Prosthesis System Gets Government Funding in Both USA and Europe - August 21st, 2013 [August 21st, 2013]
- Second Sight Medical Named 2014 Technology Pioneer - September 1st, 2013 [September 1st, 2013]
- Retinitis pigmentosa treated with acupuncture - Video - September 1st, 2013 [September 1st, 2013]
- Man Copes with Retinitis Pigmentosa - September 8th, 2013 [September 8th, 2013]
- September is healthy aging month—keep your mind active with free talking books - September 12th, 2013 [September 12th, 2013]
- Visually-impaired educator helps guide New Caney students - September 13th, 2013 [September 13th, 2013]
- Bionic eye shines light on darkness - September 15th, 2013 [September 15th, 2013]
- Football fan’s quest helps him to savor his fading sight - September 15th, 2013 [September 15th, 2013]
- Whole DNA sequencing reveals mutations, new gene for blinding disease - September 16th, 2013 [September 16th, 2013]
- This Week in PNAS - September 17th, 2013 [September 17th, 2013]
- First Self-Powered Artificial Retina Could Allow Normal Visual Acuity and Restoration of Color Vision - September 17th, 2013 [September 17th, 2013]
- Bionic eye offers gift of sight - September 24th, 2013 [September 24th, 2013]
- Lesa Kretschmer, CEO of Florida Reading & Vision Technology Inc., Named Honorary Chair of the 2013 South Florida ... - September 26th, 2013 [September 26th, 2013]
- Blind Yuba City man: ‘I walk every day, rain or shine’ - September 30th, 2013 [September 30th, 2013]
- Sun Pharma ties up with US company to offer new treatment of ocular diseases - October 1st, 2013 [October 1st, 2013]
- Sun Pharma and Intrexon Form Joint Venture to Develop New Class of Therapeutics for Ocular Diseases - October 1st, 2013 [October 1st, 2013]
- Sun Pharma inks joint venture with Intrexon - October 2nd, 2013 [October 2nd, 2013]
- NIH Scientists Pursue New Therapies To Improve Rare Disease Drug Development - October 2nd, 2013 [October 2nd, 2013]
- New bionic eye may help restore some vision in blind - October 8th, 2013 [October 8th, 2013]
- Trio heading to B.C. to join finish of Craig Gives Back tour - October 8th, 2013 [October 8th, 2013]
- Simple urine test could help diagnose eye disease - October 9th, 2013 [October 9th, 2013]
- The Low Vision Exam: Low Vision Specialists of Maryland and Virginia #3: - Video - October 10th, 2013 [October 10th, 2013]
- Blind cyclist nearing Penticton - October 10th, 2013 [October 10th, 2013]
- Retinitis Pigmentosa: Almost normal vision after 12 months treatment - Video - October 10th, 2013 [October 10th, 2013]
- Kelly: Steve Lonegan's passion fueled by challenges - October 13th, 2013 [October 13th, 2013]
- Glasses for Macular Degeneration: Low Vision Specialists of Maryland and Virginia #5 - Video - October 13th, 2013 [October 13th, 2013]
- Simple blood or urine test to identify blinding disease - October 16th, 2013 [October 16th, 2013]
- Blind Florida running back reaches the end zone during game - October 18th, 2013 [October 18th, 2013]
- Retinal Prosthesis System: 2014 Medical Innovation No. 1 - Video - October 20th, 2013 [October 20th, 2013]
- RetroSense Therapeutics Selected by Windhover as a “Top Project to Watch: Most Licensable Product” - October 28th, 2013 [October 28th, 2013]
- Retinitis Pigmentosa Treatment - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa - Genetics Home Reference - October 31st, 2013 [October 31st, 2013]
- Retinitis Pigmentosa Symptoms, Signs, Treatment, Causes, Research ... - October 31st, 2013 [October 31st, 2013]
- Foundation Fighting Blindness - What is Retinitis Pigmentosa? - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa - RNIB - RNIB - supporting blind and ... - October 31st, 2013 [October 31st, 2013]
- Retinitis pigmentosa: MedlinePlus Medical Encyclopedia - November 9th, 2013 [November 9th, 2013]
- Retinitis pigmentosa - National Library of Medicine - PubMed Health - November 11th, 2013 [November 11th, 2013]
- Retinitis Pigmentosa 11-06-2013 - Video - November 13th, 2013 [November 13th, 2013]
- Retinitis Pigmentosa treatment - acunova eye acupuncture after John Boel - Video - November 14th, 2013 [November 14th, 2013]
- Retinitis pigmentosa - Wikipedia, the free encyclopedia - November 21st, 2013 [November 21st, 2013]
- Retinitis pigmentosa | University of Maryland Medical Center - November 21st, 2013 [November 21st, 2013]
- Retinitis Pigmentosa - Low Vision - November 23rd, 2013 [November 23rd, 2013]
- Retinitis Pigmentosa or RP - AllAboutVision.com - November 26th, 2013 [November 26th, 2013]
- Retinitis Pigmentosa - Video - December 9th, 2013 [December 9th, 2013]
- RP International Spreads Holiday Cheer with The Eyes of Christmas™ - December 12th, 2013 [December 12th, 2013]
- UT Dallas Materials Scientist Research Contributes to Invention Recognized by Time Magazine - December 19th, 2013 [December 19th, 2013]
- Time is short, and sight is precious, for Sydney family living under shadow of mystery disease - December 19th, 2013 [December 19th, 2013]
- Me Driving (Prt 2) - Video - December 23rd, 2013 [December 23rd, 2013]
- Treatment of Retinitis Pigmentosa: normal vision after 9 months - Video - December 28th, 2013 [December 28th, 2013]
- Seeing Tomorrow - Video - January 1st, 2014 [January 1st, 2014]
- Edible batteries to power pacemakers + more - January 2nd, 2014 [January 2nd, 2014]
- How to cure blindness, concussions and baldness - January 2nd, 2014 [January 2nd, 2014]
- Matthew unlocks the iPad for blind and partially-sighted - January 4th, 2014 [January 4th, 2014]
- How poor eyesight led to a great vision - January 5th, 2014 [January 5th, 2014]
- Tea Thyme in Texas fundraiser set to be held at The Overlook - January 10th, 2014 [January 10th, 2014]
- Ballard author has hope that heals - January 11th, 2014 [January 11th, 2014]
- Distance runner knows the joy of competition - January 14th, 2014 [January 14th, 2014]
- Gene Therapy Tested as a Way to Stop Blindness - January 16th, 2014 [January 16th, 2014]
- Treatment may save thousands from blindness - January 16th, 2014 [January 16th, 2014]
- Gene therapy gives sight back to patients due to go blind - January 16th, 2014 [January 16th, 2014]
- Gene Therapy May Restore Sight in People With Rare Blinding Disease - January 16th, 2014 [January 16th, 2014]
- Blind Civil Rights Attorney, Athlete To Speak At Chabad House - January 17th, 2014 [January 17th, 2014]
- Visual Field Test results 4- Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 20th, 2014 [January 20th, 2014]
- Gesichtsfeldtests 2- Retinitis Pigmentosa Behandlung (Retinopathia Pigmentosa) - FIRATLI KLINIK - Video - January 20th, 2014 [January 20th, 2014]
- Visual Field Test results 3-Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Visual Field Test Results 2- Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Visual field test results 1-Medical Evidence of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 21st, 2014 [January 21st, 2014]
- Mass. Eye and Ear physician awarded RPB Career Development Award - January 23rd, 2014 [January 23rd, 2014]
- Retinitis Pigmentosa Treatment / Behandlung- FIRATLI CLINIC Proof( Visual Field Test) Eng subtitle! - Video - January 23rd, 2014 [January 23rd, 2014]
- Retinitis Pigmentosa Treatment / Behandlung- FIRATLI CLINIC German with Eng.Subtitles - Video - January 23rd, 2014 [January 23rd, 2014]
- Visual Field Results 2-Medical Proof of Retinitis Pigmentosa Treatment- FIRATLI CLINIC - Video - January 27th, 2014 [January 27th, 2014]